Collectively, these results suggested that IL‐21 increased AIM2 expression by inducing TET2 enrichment in the AIM2 promoter, leading to a reduced DNA methylation level of the AIM2 locus and enriched TFH cells, which can promote the development of SLE. Here, TET2 is linked to systemic lupus erythematosus.